SCHEMBL30450482

SCHEMBL30450482

CN(C)/C=N/c1ncc(Br)cc1I

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.36
HTT P42858 3/20 0.36
MAPT P10636 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MEN1 O00255 2/20 0.36
HBB P68871 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALOX15 P16050 2/20 0.34
RECQL P46063 1/20 0.34
KDM4E B2RXH2 5/20 0.33
ALDH1A1 P00352 4/20 0.33
GAA P10253 2/20 0.33
GLA P06280 2/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
RAB9A P51151 1/20 0.33
PLAU P00749 1/20 0.33
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19760999 1.00 L3MBTL1 (0.36) L3MBTL1HTTMAPTKMT2AMAPK1
SCHEMBL2401906 0.81 L3MBTL1 (0.38) L3MBTL1HTTMAPTKMT2AMAPK1
SCHEMBL12267661 0.81 L3MBTL1 (0.38) L3MBTL1HTTMAPTKMT2AMAPK1
SCHEMBL16926828 0.80 MAPT (0.40) L3MBTL1HTTMAPTKMT2AMAPK1
SCHEMBL31049459 0.80 ALDH1A1 (0.38) L3MBTL1HTTMAPTKMT2AMAPK1
SCHEMBL22271023 0.80 PLAU (0.50) L3MBTL1HTTMAPTKMT2AMAPK1
SCHEMBL31179122 0.72 RAB9A (0.36) L3MBTL1HTTMAPTKMT2AMAPK1
SCHEMBL19761076 0.72 PLAU (0.38) PLAU
SCHEMBL31179330 0.72 KMT2A (0.38) L3MBTL1HTTMAPTKMT2AMAPK1
SCHEMBL19761077 0.72 HTT (0.35) L3MBTL1HTTMAPTKMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11672780-B2 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds BRISTOL-MYERS SQUIBB COMPANY (US) 2023-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11672780-B2 [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds TLR7, TLR1, TLR5 L3MBTL1 4400/4885HTT 3874/4885MAPT 3696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.